Integrated Analytics Shows True Cost of Patient Care

DOWNLOAD

healthcare cost data 1To gain more efficient access to data that could reduce unwarranted variation and reduce costs, Dartmouth-Hitchcock Health (D-HH) leveraged a data platform to automate analysis of its financial data. D-HH has substantially improved its ability to use clinical, operational, and financial data to perform opportunity analysis, decrease unwarranted variation, and decrease costs.

Key Results:

  • Substantially improved the time to value—the opportunity identification processes, which would have taken three to six months before, are now completed within an hour.
  • $45K in annual cost avoidance. The organization was able to archive the legacy platform used for performing financial analysis, avoiding continued maintenance fees.

TO CONTROL HEALTHCARE SPENDING, ORGANIZATIONS MUST UNDERSTAND HEALTHCARE COST DATA

Annual U.S. healthcare spending exceeded $3.65 trillion in 2018.1 A lack of understanding of how much it costs to deliver patient care contributes to these high costs.2

D-HH is New Hampshire’s only academic health system, serving a population of 1.9 million across New England and providing access to more than 1,800 providers in almost every area of medicine. The organization delivers care at its flagship hospital, Dartmouth-Hitchcock Medical Center in Lebanon.

THE NEED FOR TIMELIER, MORE EFFICIENT ACCESS TO COST DATA

D-HH had developed and implemented a cost accounting system for both its hospital and physician services. While the health system had invested substantial resources in integrating its cost and margin data, it still required a substantial investment in manual labor to weave the financial data together with clinical data to identify opportunities to reduce unwarranted variation and decrease cost.

Although the output of those manual labor hours was incredibly helpful and leadership depended on it to inform improvement initiatives, the process was inefficient, and data was stale by the time it was ready to distribute. The analyst could only produce healthcare cost data twice a year because developing, coding, and piecing the data together took six months. Leaders and physicians would then look at the data to identify potential unwarranted variation, and the analyst would have to go back to the database, write new code, and pull out data for the encounter, procedure, or visit of interest. The team could only evaluate one focus area every six months, limiting its ability to use the data to drive improvement.

To reduce unwarranted variation and reduce costs, D-HH needed more timely access to data and a solution that didn’t depend on one person performing hundreds of hours of manual labor.

ANALYTICS APPLICATION ENABLES CONSUMABLE VIEW OF PERFORMANCE

D-HH used the Health Catalyst® Data Operating System (DOS™) and a robust suite of analytics applications to develop the Patient-Focused Economic Analysis (PFEA) analytics application. The PFEA analytics application automates the analysis of its financial data.

The health system can now review clinical, financial, and operational performance measures in a consumable way, and can leverage the data to take timely, appropriate actions to improve performance against key outcomes, such as charges and expected reimbursement.

D-HH uses the PFEA analytics application to identify clinical variation and determine whether it is unwarranted. The health system partners with physicians and service line leaders to conduct an opportunity analysis—reviewing variation, identifying if the variation is unwarranted, and assessing if there is an opportunity to decrease unwarranted variation and decrease costs. The analytics application includes variation by DRG, including identifying the number of dollars for each opportunity. Potential opportunities appear by diagnosis/procedure or by provider (see Figure 1).

Figure 1: Patient Focused Economic Analysis sample visualization

With access to a comprehensive data set, D-HH can quickly drill into opportunities and has already identified opportunities to improve the specificity and accuracy of clinical documentation, decrease delays in care related to differences in service delivery on weekends, and substantially reduce drug costs for patients.

RESULTS

D-HH has substantially improved its ability to use clinical, operational, and financial data to perform opportunity analysis, decrease unwarranted variation, and decrease costs. The organization has:

  • Substantially improved the time to value of the opportunity identification processes, reducing the time from three to six months to within one hour.
  • Archived the legacy platform used for performing financial analysis, avoiding annual continued maintenance fees of $45K.
  • Established a stable, automated system it can sustain well into the future without any additional maintenance costs.
“We can now perform a comprehensive financial analysis, and I’m amazed by how flexible and nimble we now are.” – Elizabeth Stedina, MBA, MS, VP of Data Analytics

WHAT’S NEXT

D-HH has initiated a formal project to expand the use of the analytics application to improve its opportunity identification process further, enabling the organization to drive down healthcare costs and improve outcomes.

REFERENCES

DOWNLOAD

Loading next article...